The company said the suspension affects only the Washington facility and only controlled substance shipments from that facility. Steps are being taken to ensure continuity of service to its customers.
The Drug Enforcement Administration (DEA) said that Cardinal Health “failed to maintain effective controls against the diversion of a particular controlled substance,” and cites the sale of hydrocodone, a painkiller, to one pharmacy that allegedly dispensed excessive amounts of the drug based on illegitimate prescriptions from internet pharmacy web sites.